Man Group’s Pfizer PFE Stock Holding History

Man Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.9M	Buy	461,100 +456,500	+9,924%	+$12.2M	0.02%	696
2025 Q4	$115K	Sell	4,600 -113,700	-96%	-$2.87M	﹤0.01%	2184
2025 Q3	$3.01M	Sell	118,300 -329,300	-74%	-$8.13M	0.01%	1264
2025 Q2	$10.8M	Buy	447,600 +77,200	+21%	+$1.8M	0.02%	748
2025 Q1	$9.39M	Buy	370,400 +336,100	+980%	+$8.79M	0.02%	754
2024 Q4	$910K	Sell	34,300 -103,800	-75%	-$2.82M	﹤0.01%	1511
2024 Q3	$4M	Buy	138,100 +1,200	+0.9%	+$35K	0.01%	1102
2024 Q2	$3.83M	Buy	136,900 +35,700	+35%	+$983K	0.01%	1119
2024 Q1	$2.81M	Sell	101,200 -12,000	-11%	-$333K	0.01%	1180
2023 Q4	$3.26M	Buy	+113,200	New	+$3.42M	0.01%	1121

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Man Group's PFE Position: Q1 2026 in Review

Man Group reduced its Pfizer (PFE) stake by 61% in Q1 2026, selling an estimated $41M and leaving 986,121 shares worth $27.7M. The position accounts for 0.05% of the portfolio, ranked #382.

Man Group first reported a position in PFE in Q1 2018 and has held it in 30 quarters since. The position peaked at $117M in Q1 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Man Group held 986,121 shares of Pfizer worth $27.7M as of Q1 2026.
Man Group sold 1,539,479 Pfizer shares in Q1 2026, an estimated $41M.
Pfizer made up 0.05% of Man Group's portfolio in Q1 2026, its #382 holding.
Man Group first reported a position in Pfizer in Q1 2018 and has held it in 30 quarters since.
Man Group's Pfizer position peaked at $117M in Q1 2022.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.